{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T01:19:23Z","timestamp":1773364763710,"version":"3.50.1"},"reference-count":36,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100008801","name":"Atlanta Clinical and Translational Science Institute","doi-asserted-by":"publisher","award":["UL1\u2010TR000454"],"award-info":[{"award-number":["UL1\u2010TR000454"]}],"id":[{"id":"10.13039\/100008801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010511","name":"Clinical and Translational Science Institute, University of California, San Francisco","doi-asserted-by":"publisher","award":["UL1\u2010TR000004"],"award-info":[{"award-number":["UL1\u2010TR000004"]}],"id":[{"id":"10.13039\/100010511","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01\u2010HD\u2010032632"],"award-info":[{"award-number":["U01\u2010HD\u2010032632"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01\u2010AI\u2010031834"],"award-info":[{"award-number":["U01\u2010AI\u2010031834"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01\u2010AI\u2010034989"],"award-info":[{"award-number":["U01\u2010AI\u2010034989"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01\u2010AI\u2010034993"],"award-info":[{"award-number":["U01\u2010AI\u2010034993"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01\u2010AI\u2010034994"],"award-info":[{"award-number":["U01\u2010AI\u2010034994"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01\u2010AI\u2010035004"],"award-info":[{"award-number":["U01\u2010AI\u2010035004"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01\u2010AI\u2010042590"],"award-info":[{"award-number":["U01\u2010AI\u2010042590"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01\u2010AI\u2010103390"],"award-info":[{"award-number":["U01\u2010AI\u2010103390"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01\u2010AI\u2010103397"],"award-info":[{"award-number":["U01\u2010AI\u2010103397"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01\u2010AI\u2010103401"],"award-info":[{"award-number":["U01\u2010AI\u2010103401"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01\u2010AI\u2010103408"],"award-info":[{"award-number":["U01\u2010AI\u2010103408"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec>\n                    <jats:title>Study Objective<\/jats:title>\n                    <jats:p>\n                      To evaluate the association between use of methadone, other central nervous system (\n                      <jats:styled-content style=\"fixed-case\">CNS<\/jats:styled-content>\n                      ) depressants, and\n                      <jats:styled-content style=\"fixed-case\">QT<\/jats:styled-content>\n                      c interval\u2013prolonging medications and risk of mortality among human immunodeficiency virus (\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      )\u2010infected and at\u2010risk\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      \u2010uninfected women.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>\n                      Multicenter, prospective, observational cohort study (Women's Interagency\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      Study [\n                      <jats:styled-content style=\"fixed-case\">WIHS<\/jats:styled-content>\n                      ]).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>\n                      A total of 4150 women enrolled in the\n                      <jats:styled-content style=\"fixed-case\">WIHS<\/jats:styled-content>\n                      study between 1994 and 2014 who were infected (3119 women) or not infected (1031 women) with\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>\n                      Data on medication utilization were collected from all study participants via interviewer\u2010administered surveys at 6\u2010month intervals (1994\u20132014). Mortality was confirmed by National Death Index data. With age defining the time scale for the analysis, Cox proportional hazards models were used to estimate hazard ratios (\n                      <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                      s) for all\u2010cause mortality in\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      \u2010infected and \u2010uninfected women and non\u2013acquired immunodeficiency syndrome (\n                      <jats:styled-content style=\"fixed-case\">AIDS<\/jats:styled-content>\n                      ) deaths in\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      \u2010infected women. A total of 1046 deaths were identified, of which 429 were considered non\u2010\n                      <jats:styled-content style=\"fixed-case\">AIDS<\/jats:styled-content>\n                      deaths. Use of benzodiazepines,\n                      <jats:styled-content style=\"fixed-case\">CNS<\/jats:styled-content>\n                      depressants (excluding methadone), and number of medications with conditional\n                      <jats:styled-content style=\"fixed-case\">QT<\/jats:styled-content>\n                      c interval\u2013prolonging effects were each associated with all\u2010cause mortality in multivariate models of\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      \u2010infected women: hazard ratio (\n                      <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                      ) 1.28, 95% confidence interval (\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      ) 1.01\u20131.60, p=0.037;\n                      <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                      1.61, 95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      1.35\u20131.92, p&lt;0.0001; and\n                      <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                      1.15 per drug, 95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      1.00\u20131.33, p=0.047, respectively. Other explanatory variables for all\u2010cause mortality in this model included\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      viral load,\n                      <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>\n                      4\n                      <jats:sup>+<\/jats:sup>\n                      \u00a0cell count, renal function, hemoglobin and albumin levels,\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      treatment era, employment status, existence of depressive symptoms, ever use of injection drugs, and tobacco smoking. Of interest, use of\n                      <jats:styled-content style=\"fixed-case\">CNS<\/jats:styled-content>\n                      depressants (excluding methadone) was also associated with non\u2010\n                      <jats:styled-content style=\"fixed-case\">AIDS<\/jats:styled-content>\n                      deaths (\n                      <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                      1.49, 95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      1.49\u20132.2, p&lt;0.0001). Although use of benzodiazepines and conditional\n                      <jats:styled-content style=\"fixed-case\">QT<\/jats:styled-content>\n                      interval\u2013prolonging medications were associated with increased risk of non\u2010\n                      <jats:styled-content style=\"fixed-case\">AIDS<\/jats:styled-content>\n                      mortality (\n                      <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                      1.32 and 1.25, respectively), the effect was not statistically significant (p&gt;0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      In this cohort of\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      \u2010infected and at\u2010risk\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      \u2010uninfected women, use of benzodiazepines,\n                      <jats:styled-content style=\"fixed-case\">CNS<\/jats:styled-content>\n                      depressants, and conditional\n                      <jats:styled-content style=\"fixed-case\">QT<\/jats:styled-content>\n                      c interval\u2013prolonging medications were associated with a higher risk of mortality independent of methadone and other well\u2010recognized mortality risk factors. Care must be taken to assess risk when prescribing these medications in this underserved and at\u2010risk patient population.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/phar.2312","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T22:53:15Z","timestamp":1563835995000},"page":"899-911","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between Use of Methadone, Other Central Nervous System Depressants, and\n                    <scp>QT<\/scp>\n                    c Interval\u2013Prolonging Medications and Risk of Mortality in a Large Cohort of Women Living with or at Risk for Human Immunodeficiency Virus Infection"],"prefix":"10.1002","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7341-455X","authenticated-orcid":false,"given":"Bani","family":"Tamraz","sequence":"first","affiliation":[{"name":"School of Pharmacy University of California, San Francisco San Francisco California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Reisner","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery University of California, San Francisco San Francisco California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey L.","family":"French","sequence":"additional","affiliation":[{"name":"Infectious Diseases CORE Center\/Stroger Hospital of Cook County Chicago Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel T.","family":"King","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice University of Mississippi School of Pharmacy Jackson Mississippi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret A.","family":"Fischl","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Miller School of Medicine University of Miami Miami Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igho","family":"Ofotokun","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Department of Medicine School of Medicine Emory University Atlanta Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Kashuba","sequence":"additional","affiliation":[{"name":"School of Pharmacy UNC Eshelman University of North Carolina (UNC) Center for AIDS Research Chapel Hill North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Milam","sequence":"additional","affiliation":[{"name":"Keck School of Medicine University of Southern California Los Angeles California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry","family":"Murphy","sequence":"additional","affiliation":[{"name":"Department of Medicine Albert Einstein College of Medicine Bronx New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Augenbraun","sequence":"additional","affiliation":[{"name":"Infectious Diseases State University of New York Downstate Medical Center Brooklyn New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenglong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medicine Georgetown University Medical Center Washington District of Columbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick R.","family":"Finley","sequence":"additional","affiliation":[{"name":"School of Pharmacy University of California, San Francisco San Francisco California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"Aouizerat","sequence":"additional","affiliation":[{"name":"School of Dentistry and Bluestone Center for Clinical Research New York University New York New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Cocohoba","sequence":"additional","affiliation":[{"name":"School of Pharmacy University of California, San Francisco San Francisco California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Gange","sequence":"additional","affiliation":[{"name":"John Hopkins Bloomberg School of Public Health Baltimore Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bacchetti","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics School of Medicine University of California, San Francisco San Francisco California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth M.","family":"Greenblatt","sequence":"additional","affiliation":[{"name":"School of Pharmacy University of California, San Francisco San Francisco California"},{"name":"Department of Epidemiology and Biostatistics School of Medicine University of California, San Francisco San Francisco California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,8,13]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3776"},{"key":"e_1_2_7_3_1","first-page":"1","article-title":"Drug poisoning deaths in the United States, 1980\u20132008","volume":"81","author":"Warner M","year":"2011","journal-title":"NCHS Data Brief"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02650.x"},{"issue":"26","key":"e_1_2_7_5_1","first-page":"493","article-title":"Vital signs: risk for overdose from methadone used for pain relief \u2013 United States, 1999\u20132010","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2008.802"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.20.2288-c"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-10-201305210-00008"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-6-200903170-00103"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.23.6.802.32186"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit467"},{"issue":"7","key":"e_1_2_7_12_1","first-page":"690","article-title":"Sex differences in the evolution of the electrocardiographic QT interval with age","volume":"8","author":"Rautaharju PM","year":"1992","journal-title":"Can J Cardiol"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058812"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6113.1000365"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.12.9.1013-1019.2005"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199803000-00004"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01169-5"},{"key":"e_1_2_7_18_1","unstructured":"WoosleyR RomeroK. QTdrugs List AZCERT Inc. 1822 Innovation Park Dr. Oro Valley AZ 85755.www.Crediblemeds.org. Accessed October 2015."},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2017.07.010"},{"key":"e_1_2_7_20_1","unstructured":"U.S. Food and Drug Administration.Drug development and drug interactions: Table of substrates inhibitors and inducers. Available from:http:\/\/www.fda.gov\/drugs\/developmentapprovalprocess\/developmentresources\/druginteractionslabeling\/ucm093664.htm. Accessed October 2015"},{"key":"e_1_2_7_21_1","unstructured":"Drug interactions database. Ann Arbor (MI): Truven Health Analytics; publication year. Available from:www.micromedexsolutions.com. Subscription required to view. Accessed October 2015."},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-4-200402170-00007"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181e674f4"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200005050-00013"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200305010-00010"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/jech.56.2.153"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1086\/424013"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000078"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181cc1070"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1996"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2008.12.004"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-000850"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.22.2942"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674371105600609"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2318-15-2"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6450a3"},{"issue":"40","key":"e_1_2_7_37_1","first-page":"881","article-title":"Alcohol involvement in opioid pain reliever and benzodiazepine drug abuse\u2013related emergency department visits and drug\u2010related deaths \u2014 United States, 2010","volume":"63","author":"Jones CM","year":"2014","journal-title":"Morb Mortal Wkly Rep"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.2312","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/phar.2312","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.2312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:53:18Z","timestamp":1761069198000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/phar.2312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,13]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1002\/phar.2312"],"URL":"https:\/\/doi.org\/10.1002\/phar.2312","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,13]]},"assertion":[{"value":"2019-08-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}